Market Overview:
The global Apixaban API market is projected to reach a high compound annual growth rate (CAGR) during the forecast period from 2024 to 2031. Apixaban, a white to pale yellow powder used as an anticoagulant, is marketed under the trade name Eliquis. It works by inhibiting blood clot formation to treat and prevent thromboembolic diseases.
Market Dynamics:
The rise in venous...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian